Position in UTHR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,279,065
New position
Shares Held
10,589
first reported quarter
Ownership
0.025%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Summit Financial, LLC holds $9,165,721 across 6 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (68.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
10,589 | $6,279,065 | |
| 2 | DERM |
Journey Medical Corp
|
379,807 | $1,781,294 | |
| 3 | ZTS |
Zoetis Inc.
|
4,301 | $508,421 | |
| 4 | ESPR |
Esperion Therapeutics, Inc.
|
126,373 | $346,262 | |
| 5 | CRDL |
Cardiol Therapeutics Inc.
|
104,059 | $140,479 | |
| 6 | HLN |
Haleon plc
|
11,009 | $110,200 |
All Filings in UTHR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,279,065 | 10,589 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||